Skip to main content
Top
Published in: Heart Failure Reviews 4/2013

Open Access 01-07-2013

Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure

Authors: Kieran E. Brack, James Winter, G. André Ng

Published in: Heart Failure Reviews | Issue 4/2013

Login to get access

Abstract

Classical physiology teaches that vagal post-ganglionic nerves modulate the heart via acetylcholine acting at muscarinic receptors, whilst it is accepted that vagus nerve stimulation (VNS) slows heart rate, atrioventricular conduction and decreases atrial contraction; there is continued controversy as to whether the vagus has any significant direct effect on ventricular performance. Despite this, there is a significant body of evidence from experimental and clinical studies, demonstrating that the vagus nerve has an anti-arrhythmic action, protecting against induced and spontaneously occurring ventricular arrhythmias. Over 100 years ago Einbrodt first demonstrated that direct cervical VNS significantly increased the threshold for experimentally induced ventricular fibrillation. A large body of evidence has subsequently been collected supporting the existence of an anti-arrhythmic effect of the vagus on the ventricle. The development of prognostic indicators of heart rate variability and baroreceptor reflex sensitivity—measures of parasympathetic tone and reflex activation respectively—and the more recent interest in chronic VNS therapy are a direct consequence of the earlier experimental studies. Despite this, mechanisms underlying the anti-arrhythmic actions of the vagus nerve have not been fully characterised and are not well understood. This review summarises historical and recently published data to highlight the importance of this powerful endogenous protective phenomenon.
Literature
3.
go back to reference Ishise H, Asanoi H, Ishizaka S, Joho S, Kameyama T, Umeno K, Inoue H (1998) Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol 84:1234–1241PubMed Ishise H, Asanoi H, Ishizaka S, Joho S, Kameyama T, Umeno K, Inoue H (1998) Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol 84:1234–1241PubMed
4.
go back to reference Motte S, Mathieu M, Brimioulle S, Pensis A, Ray L, Ketelslegers JM, Montano N, Naeije R, van de Borne P, Entee KM (2005) Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol 289:H1729–H1735PubMedCrossRef Motte S, Mathieu M, Brimioulle S, Pensis A, Ray L, Ketelslegers JM, Montano N, Naeije R, van de Borne P, Entee KM (2005) Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol 289:H1729–H1735PubMedCrossRef
5.
go back to reference Sun SY, Wang W, Zucker IH, Schultz HD (1999) Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86(4):1273–1282PubMed Sun SY, Wang W, Zucker IH, Schultz HD (1999) Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86(4):1273–1282PubMed
6.
go back to reference Ma R, Zucker IH, Wang W (1997) Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. Am J Physiol 273:H2664–H2671PubMed Ma R, Zucker IH, Wang W (1997) Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. Am J Physiol 273:H2664–H2671PubMed
7.
go back to reference Grassi G, Seravalle G, Bertinieri G, Turri C, Stella ML, Scopelliti F, Mancia G (2001) Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci (Lond) 101:141–146CrossRef Grassi G, Seravalle G, Bertinieri G, Turri C, Stella ML, Scopelliti F, Mancia G (2001) Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci (Lond) 101:141–146CrossRef
8.
go back to reference Schwartz PJ (1998) The autonomic nervous system and sudden death. Eur Heart J 19(Suppl F):F72–F80 Schwartz PJ (1998) The autonomic nervous system and sudden death. Eur Heart J 19(Suppl F):F72–F80
9.
go back to reference Floras JS (2003) Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177:391–398PubMedCrossRef Floras JS (2003) Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177:391–398PubMedCrossRef
10.
go back to reference Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus K-L, Janosi A, Thorgeirsson G, Dunselman PHJM, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P, for the MERIT-HF Study Group (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) JAMA 283:1295–1302 Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus K-L, Janosi A, Thorgeirsson G, Dunselman PHJM, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P, for the MERIT-HF Study Group (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) JAMA 283:1295–1302
11.
go back to reference Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98:1510–1516PubMedCrossRef Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98:1510–1516PubMedCrossRef
12.
go back to reference La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Sleight P, Febo O (2009) Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 53:193–199PubMedCrossRef La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Sleight P, Febo O (2009) Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 53:193–199PubMedCrossRef
13.
go back to reference Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JMM, Fox KAA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 98:1510–1516PubMedCrossRef Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JMM, Fox KAA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 98:1510–1516PubMedCrossRef
14.
go back to reference La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351:478–484PubMedCrossRef La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351:478–484PubMedCrossRef
15.
go back to reference Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59:256–262PubMedCrossRef Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59:256–262PubMedCrossRef
16.
go back to reference Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN (1992) Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85:164–171PubMedCrossRef Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN (1992) Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85:164–171PubMedCrossRef
17.
go back to reference La Rovere M, Specchia G, Mortara A, Schwartz P (1988) Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 78:816–824PubMedCrossRef La Rovere M, Specchia G, Mortara A, Schwartz P (1988) Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 78:816–824PubMedCrossRef
18.
go back to reference Billman G, Schwartz P, Stone H (1982) Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 66:874–880PubMedCrossRef Billman G, Schwartz P, Stone H (1982) Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 66:874–880PubMedCrossRef
19.
go back to reference De Ferrari GM, Vanoli E, Stramba-Badiale M, Hull SS, Foreman RD, Schwartz PJ (1991) Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am J Physiol Heart Circ Physiol 261:H63–H69 De Ferrari GM, Vanoli E, Stramba-Badiale M, Hull SS, Foreman RD, Schwartz PJ (1991) Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am J Physiol Heart Circ Physiol 261:H63–H69
20.
go back to reference Schwartz P, Vanoli E, Stramba-Badiale M, De Ferrari G, Billman G, Foreman R (1988) Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78:969–979PubMedCrossRef Schwartz P, Vanoli E, Stramba-Badiale M, De Ferrari G, Billman G, Foreman R (1988) Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78:969–979PubMedCrossRef
21.
go back to reference Cerati D, Schwartz P (1991) Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. Circ Res 69:1389–1401PubMedCrossRef Cerati D, Schwartz P (1991) Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. Circ Res 69:1389–1401PubMedCrossRef
22.
go back to reference Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, Camm AJ (1992) Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 67(2):129–137PubMedCrossRef Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, Camm AJ (1992) Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 67(2):129–137PubMedCrossRef
23.
go back to reference Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ (1991) Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Col Cardiol 18:687–697CrossRef Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ (1991) Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Col Cardiol 18:687–697CrossRef
24.
go back to reference Tuininga YS, van Veldhuisen DJ, Brouwer J, Haaksma J, Crijns HJ, Man in’t Veld AJ, Lie KI (1994) Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J72:509–513CrossRef Tuininga YS, van Veldhuisen DJ, Brouwer J, Haaksma J, Crijns HJ, Man in’t Veld AJ, Lie KI (1994) Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J72:509–513CrossRef
25.
go back to reference Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ (1992) Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 67:482–485PubMedCrossRef Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ (1992) Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 67:482–485PubMedCrossRef
26.
go back to reference Brodde OE, Bruck H, Leineweber K, Seyfarth T (2001) Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96:528–538PubMedCrossRef Brodde OE, Bruck H, Leineweber K, Seyfarth T (2001) Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96:528–538PubMedCrossRef
27.
go back to reference Brack KE, Coote JH, Ng GA (2010) Vagus nerve stimulation inhibits the increase in Ca2+ transient and left ventricular force caused by sympathetic nerve stimulation but has no direct effects alone—epicardial Ca2+ fluorescence studies using fura-2 AM in the isolated innervated beating rabbit heart. Exp Physiol 95:80–92PubMedCrossRef Brack KE, Coote JH, Ng GA (2010) Vagus nerve stimulation inhibits the increase in Ca2+ transient and left ventricular force caused by sympathetic nerve stimulation but has no direct effects alone—epicardial Ca2+ fluorescence studies using fura-2 AM in the isolated innervated beating rabbit heart. Exp Physiol 95:80–92PubMedCrossRef
28.
go back to reference Rysevaite K, Saburkina I, Pauziene N, Vaitkevicius R, Noujaim SF, Jalife J, Pauza DH (2011) Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations. Heart Rhythm 8:731–738PubMedCrossRef Rysevaite K, Saburkina I, Pauziene N, Vaitkevicius R, Noujaim SF, Jalife J, Pauza DH (2011) Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations. Heart Rhythm 8:731–738PubMedCrossRef
29.
go back to reference Rysevaite K, Saburkina I, Pauziene N, Noujaim SF, Jalife J, Pauza DH (2011) Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart. Heart Rhythm 8:448–454PubMedCrossRef Rysevaite K, Saburkina I, Pauziene N, Noujaim SF, Jalife J, Pauza DH (2011) Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart. Heart Rhythm 8:448–454PubMedCrossRef
30.
go back to reference Batulevicius D, Pauziene N, Pauza DH (2005) Architecture and age-related analysis of the neuronal number of the guinea pig intrinsic cardiac nerve plexus. Ann Anat 187:225–243PubMedCrossRef Batulevicius D, Pauziene N, Pauza DH (2005) Architecture and age-related analysis of the neuronal number of the guinea pig intrinsic cardiac nerve plexus. Ann Anat 187:225–243PubMedCrossRef
31.
go back to reference Johnson TA, Gray AL, Lauenstein JM, Newton SS, Massari VJ (2004) Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. J Appl Physiol 96:2265–2272PubMedCrossRef Johnson TA, Gray AL, Lauenstein JM, Newton SS, Massari VJ (2004) Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. J Appl Physiol 96:2265–2272PubMedCrossRef
32.
go back to reference Pauza DH, Skripka V, Pauziene N (2002) Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing histochemical staining with acetylcholinesterase. Cells Tissues Organs 172:297–320PubMedCrossRef Pauza DH, Skripka V, Pauziene N (2002) Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing histochemical staining with acetylcholinesterase. Cells Tissues Organs 172:297–320PubMedCrossRef
33.
go back to reference Ulphani JS, Cain JH, Inderyas F, Gordon D, Gikas PV, Shade G, Mayor D, Arora R, Kadish AH, Goldberger JJ (2010) Quantitative analysis of parasympathetic innervation of the porcine heart. Heart Rhythm 7:1113–1119PubMedCrossRef Ulphani JS, Cain JH, Inderyas F, Gordon D, Gikas PV, Shade G, Mayor D, Arora R, Kadish AH, Goldberger JJ (2010) Quantitative analysis of parasympathetic innervation of the porcine heart. Heart Rhythm 7:1113–1119PubMedCrossRef
34.
go back to reference Saburkina I, Rysevaite K, Pauziene N, Mischke K, Schauerte P, Jalife J, Pauza DH (2010) Epicardial neural ganglionated plexus of ovine heart: anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery. Heart Rhythm 7:942–950PubMedCrossRef Saburkina I, Rysevaite K, Pauziene N, Mischke K, Schauerte P, Jalife J, Pauza DH (2010) Epicardial neural ganglionated plexus of ovine heart: anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery. Heart Rhythm 7:942–950PubMedCrossRef
35.
go back to reference Pauza DH, Skripka V, Pauziene N, Stropus R (2000) Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 259:353–382PubMedCrossRef Pauza DH, Skripka V, Pauziene N, Stropus R (2000) Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 259:353–382PubMedCrossRef
36.
go back to reference Kawano H, Okada R, Yano K (2003) Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18:32–39PubMedCrossRef Kawano H, Okada R, Yano K (2003) Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18:32–39PubMedCrossRef
37.
go back to reference Armour JA (1996) Anatomy and function of peripheral autonomic neurons involved in cardiac regulation. In: Shepard VT, Vatner SF (eds) Nervous control of the heart, 1st edn. Harwood academic publishers, London, pp 29–48 Armour JA (1996) Anatomy and function of peripheral autonomic neurons involved in cardiac regulation. In: Shepard VT, Vatner SF (eds) Nervous control of the heart, 1st edn. Harwood academic publishers, London, pp 29–48
38.
go back to reference Ng GA, Brack KE, Coote JH (2001) Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart—a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation. Exp Physiol 86:319 Ng GA, Brack KE, Coote JH (2001) Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart—a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation. Exp Physiol 86:319
39.
go back to reference Ardell JL, Randall WC (1986) Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. Am J Physiol 251:H764–H773PubMed Ardell JL, Randall WC (1986) Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. Am J Physiol 251:H764–H773PubMed
40.
go back to reference Armour JA (1976) Instant to instant reflex cardiac regulation. Cardiology 61:309–328CrossRef Armour JA (1976) Instant to instant reflex cardiac regulation. Cardiology 61:309–328CrossRef
41.
go back to reference Armour JA (2008) Potential clinical relevance of the ‘little brain’ on the mammalian heart. Exp Physiol 93:165–176PubMedCrossRef Armour JA (2008) Potential clinical relevance of the ‘little brain’ on the mammalian heart. Exp Physiol 93:165–176PubMedCrossRef
42.
go back to reference Huang MH, Wolf SG, Armour JA (1994) Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones. Cardiovasc Res 28:636–642PubMedCrossRef Huang MH, Wolf SG, Armour JA (1994) Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones. Cardiovasc Res 28:636–642PubMedCrossRef
43.
go back to reference Bibevski S, Dunlap M (1999) Evidence of impaired vagus nerve activity. Heart Failure 99(22):2958–2963 Bibevski S, Dunlap M (1999) Evidence of impaired vagus nerve activity. Heart Failure 99(22):2958–2963
44.
go back to reference Dhein S, van Koppen CJ, Brodde O (2001) Muscarinic receptors in the mammalian heart. Pharmacol Res 44:161–182PubMedCrossRef Dhein S, van Koppen CJ, Brodde O (2001) Muscarinic receptors in the mammalian heart. Pharmacol Res 44:161–182PubMedCrossRef
45.
go back to reference Stengel PW, Gomeza J, Wess J, Cohen ML (2002) M2 and M4 receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro Pharmacol Exp Therap 292:877–885 Stengel PW, Gomeza J, Wess J, Cohen ML (2002) M2 and M4 receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro Pharmacol Exp Therap 292:877–885
46.
go back to reference Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS (2008) Parasympathetic nervous system in heart failure: pathophysiology and potential implications for therapy. Circulation 118:862–871CrossRef Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS (2008) Parasympathetic nervous system in heart failure: pathophysiology and potential implications for therapy. Circulation 118:862–871CrossRef
47.
go back to reference Hoover DB, Baisden RH, Xi-Mov SX (1994) Localization of muscarinic receptors mRNAs in rat heart and intrinsic ganglia by in situ hybridisation. Circ Res 75:813–820PubMedCrossRef Hoover DB, Baisden RH, Xi-Mov SX (1994) Localization of muscarinic receptors mRNAs in rat heart and intrinsic ganglia by in situ hybridisation. Circ Res 75:813–820PubMedCrossRef
48.
go back to reference Karasawa Y, Furukawa Y, Ren LM, Takei M, Murakami M, Narita M, Chiba S (1990) Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. Eur J Pharmacol 187:9–17PubMedCrossRef Karasawa Y, Furukawa Y, Ren LM, Takei M, Murakami M, Narita M, Chiba S (1990) Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. Eur J Pharmacol 187:9–17PubMedCrossRef
49.
go back to reference Einbrodt (1859) Ueber Herzreizung und ihr Verhaeltnis zum Blutdruck. Akademie der Wissenschaften (Vienna) Sitzungsberichte 38:345 Einbrodt (1859) Ueber Herzreizung und ihr Verhaeltnis zum Blutdruck. Akademie der Wissenschaften (Vienna) Sitzungsberichte 38:345
50.
go back to reference Scherlag BJ, Helfant RH, Haft JI, Damato AN (1970) Electrophysiology underlying ventricular arrhythmias due to coronary ligation. Am J Physiol 219:1665–1671PubMed Scherlag BJ, Helfant RH, Haft JI, Damato AN (1970) Electrophysiology underlying ventricular arrhythmias due to coronary ligation. Am J Physiol 219:1665–1671PubMed
51.
go back to reference Goldstein RE, Karsh RB, Smith ER, Orlando M, Norman D, Farnham G, Redwood DR, Epstein SE (1973) Influence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation 47:1180–1190PubMedCrossRef Goldstein RE, Karsh RB, Smith ER, Orlando M, Norman D, Farnham G, Redwood DR, Epstein SE (1973) Influence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation 47:1180–1190PubMedCrossRef
52.
go back to reference Myers RW, Pearlman AS, Hyman RM, Goldstein RA, Kent KM, Goldstein RE, Epstein SE (1974) Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation 49:943–947PubMedCrossRef Myers RW, Pearlman AS, Hyman RM, Goldstein RA, Kent KM, Goldstein RE, Epstein SE (1974) Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation 49:943–947PubMedCrossRef
53.
go back to reference Waxman H, Cain M, Greenspan A, Josephson M (1982) Termination of ventricular tachycardia with ventricular stimulation: salutary effect of increased current strength. Circulation 65:800–804PubMedCrossRef Waxman H, Cain M, Greenspan A, Josephson M (1982) Termination of ventricular tachycardia with ventricular stimulation: salutary effect of increased current strength. Circulation 65:800–804PubMedCrossRef
54.
go back to reference Kolman B, Verrier R, Lown B (1975) The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions. Circulation 52:578–585PubMedCrossRef Kolman B, Verrier R, Lown B (1975) The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions. Circulation 52:578–585PubMedCrossRef
55.
go back to reference Yoon MS, Han J, Tse WW, Rogers R (1977) Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J 93:60–65PubMedCrossRef Yoon MS, Han J, Tse WW, Rogers R (1977) Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J 93:60–65PubMedCrossRef
56.
go back to reference Kent KM, Smith ER, Redwood DR, Epstein SE (1973) Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation 47:291–298PubMedCrossRef Kent KM, Smith ER, Redwood DR, Epstein SE (1973) Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation 47:291–298PubMedCrossRef
57.
go back to reference Corr PB, Gillis RA (1974) Role of the vagus in the cardiovascular changes induced by coronary artery occlusion. Circulation 49:86–97PubMedCrossRef Corr PB, Gillis RA (1974) Role of the vagus in the cardiovascular changes induced by coronary artery occlusion. Circulation 49:86–97PubMedCrossRef
58.
go back to reference Zuanetti G, De Ferrari GM, Priori SG, Schwartz PJ (1987) Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 61:429–435PubMedCrossRef Zuanetti G, De Ferrari GM, Priori SG, Schwartz PJ (1987) Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 61:429–435PubMedCrossRef
59.
go back to reference Schwartz PJ, Billman GE, Stone HL (1984) Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 69:790–800PubMedCrossRef Schwartz PJ, Billman GE, Stone HL (1984) Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 69:790–800PubMedCrossRef
60.
go back to reference Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ (1991) Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68:1471–1481PubMedCrossRef Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ (1991) Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68:1471–1481PubMedCrossRef
61.
go back to reference Weiss JN, Chen P-S, Qu Z, Karagueuzian HS, Garfinkel A (2000) Ventricular fibrillation: how do we stop the waves from breaking? Circ Res 87:1103–1107PubMedCrossRef Weiss JN, Chen P-S, Qu Z, Karagueuzian HS, Garfinkel A (2000) Ventricular fibrillation: how do we stop the waves from breaking? Circ Res 87:1103–1107PubMedCrossRef
62.
go back to reference Cao JM, Qu Z, Kim YH, Wu TJ, Garfinkel A, Weiss JN, Karagueuzian HS, Chen PS (1999) Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res 84:1318–1331PubMedCrossRef Cao JM, Qu Z, Kim YH, Wu TJ, Garfinkel A, Weiss JN, Karagueuzian HS, Chen PS (1999) Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res 84:1318–1331PubMedCrossRef
63.
go back to reference Nolasco JB, Dahlen RW (1968) A graphic method for the study of alternation in cardiac action potentials. J Appl Physiol 25:191–196PubMed Nolasco JB, Dahlen RW (1968) A graphic method for the study of alternation in cardiac action potentials. J Appl Physiol 25:191–196PubMed
64.
go back to reference Karma A (1994) Electrical alternans and spiral wave breakup in cardiac tissue. Chaos 4(3):461–472PubMedCrossRef Karma A (1994) Electrical alternans and spiral wave breakup in cardiac tissue. Chaos 4(3):461–472PubMedCrossRef
65.
go back to reference Gilmour RF Jr, Chialvo DR (1999) Electrical restitution, critical mass, and the riddle of fibrillation. J Cardiovasc Electrophysiol 10:1087–1089PubMedCrossRef Gilmour RF Jr, Chialvo DR (1999) Electrical restitution, critical mass, and the riddle of fibrillation. J Cardiovasc Electrophysiol 10:1087–1089PubMedCrossRef
66.
go back to reference Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee MH, Karagueuzian HS, Weiss JN, Chen PS (2000) Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci 97:6061–6066PubMedCrossRef Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee MH, Karagueuzian HS, Weiss JN, Chen PS (2000) Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci 97:6061–6066PubMedCrossRef
67.
go back to reference Riccio ML, Koller ML, Gilmour RF Jr (1999) Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res 84:955–963PubMedCrossRef Riccio ML, Koller ML, Gilmour RF Jr (1999) Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res 84:955–963PubMedCrossRef
68.
go back to reference Ng GA, Brack KE, Patel VH, Coote JH (2007) Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res 73:750–760PubMedCrossRef Ng GA, Brack KE, Patel VH, Coote JH (2007) Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res 73:750–760PubMedCrossRef
69.
go back to reference Wei SK, Ruknudin AM, Shou M, McCurley JM, Hanlon SU, Elgin E, Schulze DH, Haigney MC (2007) Muscarinic modulation of the sodium-calcium exchanger in heart failure. Circulation 115(10):1225–1233PubMed Wei SK, Ruknudin AM, Shou M, McCurley JM, Hanlon SU, Elgin E, Schulze DH, Haigney MC (2007) Muscarinic modulation of the sodium-calcium exchanger in heart failure. Circulation 115(10):1225–1233PubMed
70.
go back to reference Laurita KR, Girouard SD, Akar FG (1998) Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. Circulation 98:2774–2780PubMedCrossRef Laurita KR, Girouard SD, Akar FG (1998) Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. Circulation 98:2774–2780PubMedCrossRef
71.
go back to reference Marshall RJ, Muir AW, Winslow E (1983) Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anesthetise rat. Br J Pharmacol 78:165–171PubMedCrossRef Marshall RJ, Muir AW, Winslow E (1983) Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anesthetise rat. Br J Pharmacol 78:165–171PubMedCrossRef
72.
go back to reference Harumi K, Tsutsumi T, Sato T, Sekiya S (1989) Classification of antiarrhythmic drugs based on ventricular fibrillation threshold Am J Cardiol 64:10J–14J Harumi K, Tsutsumi T, Sato T, Sekiya S (1989) Classification of antiarrhythmic drugs based on ventricular fibrillation threshold Am J Cardiol 64:10J–14J
73.
go back to reference Podrid PJ, Myerburg RJ (2005) Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol 28(Supp 1):I3–I11PubMed Podrid PJ, Myerburg RJ (2005) Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol 28(Supp 1):I3–I11PubMed
74.
go back to reference Maskin CS, Siskind SJ, LeJemtel TH (1984) High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J 107:896–901PubMedCrossRef Maskin CS, Siskind SJ, LeJemtel TH (1984) High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J 107:896–901PubMedCrossRef
75.
go back to reference Zheng C, Li M, Inagaki M, Kawada T, Sunagawa K, Sugimachi M (2005) Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf Proc IEEE Eng Med Bio Soc 7:7072–7075 Zheng C, Li M, Inagaki M, Kawada T, Sunagawa K, Sugimachi M (2005) Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf Proc IEEE Eng Med Bio Soc 7:7072–7075
76.
go back to reference Sabbah HN (2011) Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleavland Clin J Med 78(supp 1):S24–S29CrossRef Sabbah HN (2011) Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleavland Clin J Med 78(supp 1):S24–S29CrossRef
77.
go back to reference Wang X, Gerdes AM (1999) Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodelling. J Mol Cell Cardiol 31:333–343PubMedCrossRef Wang X, Gerdes AM (1999) Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodelling. J Mol Cell Cardiol 31:333–343PubMedCrossRef
78.
go back to reference Ai X, Pogwizd SM (2005) Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 96:54–63PubMedCrossRef Ai X, Pogwizd SM (2005) Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 96:54–63PubMedCrossRef
79.
go back to reference Behling A, Moraes RS, Rohde LE, Ferlin EL, Nobrega AC, Ribeiro JP (2003) Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146(3):495–500CrossRef Behling A, Moraes RS, Rohde LE, Ferlin EL, Nobrega AC, Ribeiro JP (2003) Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146(3):495–500CrossRef
80.
go back to reference Zhang YH, Song YC (1998) Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. Int J Cardiol 65:233–238PubMedCrossRef Zhang YH, Song YC (1998) Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. Int J Cardiol 65:233–238PubMedCrossRef
81.
go back to reference Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circ 109:120–124CrossRef Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circ 109:120–124CrossRef
82.
go back to reference Zhang Y, PopoviÄ ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN (2009) Chronic Vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model/clinical perspective. Circ Heart Fail 2:692–699 Zhang Y, PopoviÄ ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN (2009) Chronic Vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model/clinical perspective. Circ Heart Fail 2:692–699
83.
go back to reference Sabbah HN Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleve Clin J Med 78(Suppl 1):S24–S29 Sabbah HN Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleve Clin J Med 78(Suppl 1):S24–S29
84.
go back to reference Sabbah HN, Rastogi S, Mishra S, Gupta RC, Ilsar I, Imai M, Cohen U, Ben-David T, Ben-Ezra O (2005) Long-term therapy with neuroselective electric Vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure. Eur J Heart Fail Suppl 4(Suppl):166–167 Sabbah HN, Rastogi S, Mishra S, Gupta RC, Ilsar I, Imai M, Cohen U, Ben-David T, Ben-Ezra O (2005) Long-term therapy with neuroselective electric Vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure. Eur J Heart Fail Suppl 4(Suppl):166–167
85.
go back to reference De Ferrari GM, Schwartz PJ Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev 16:195–203 De Ferrari GM, Schwartz PJ Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev 16:195–203
86.
go back to reference Samaan A (1935) The antagonistic cardiac nerves and heart rate. J Physiol 83(3):332–340PubMed Samaan A (1935) The antagonistic cardiac nerves and heart rate. J Physiol 83(3):332–340PubMed
87.
go back to reference Levy MN, Zieske H (1969) Effect of enhanced contractility on the left ventricular response to vagus nerve stimulation in dogs. Circ Res 24:303–311PubMedCrossRef Levy MN, Zieske H (1969) Effect of enhanced contractility on the left ventricular response to vagus nerve stimulation in dogs. Circ Res 24:303–311PubMedCrossRef
88.
go back to reference Martin PJ, Levy MN, Zieske H (1969) Analysis and simulation of the left ventricular response to autonomic nervous activity. Cardiovasc Res 3:396–410PubMedCrossRef Martin PJ, Levy MN, Zieske H (1969) Analysis and simulation of the left ventricular response to autonomic nervous activity. Cardiovasc Res 3:396–410PubMedCrossRef
89.
go back to reference Levy MN, Blattberg B (1976) Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 38:81–84PubMedCrossRef Levy MN, Blattberg B (1976) Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 38:81–84PubMedCrossRef
90.
go back to reference Brack KE, Coote JH, Ng GA (2004) Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart. Exp Physiol 89:128–139PubMedCrossRef Brack KE, Coote JH, Ng GA (2004) Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart. Exp Physiol 89:128–139PubMedCrossRef
91.
go back to reference Muscholl E (1980) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239:H713–H720PubMed Muscholl E (1980) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239:H713–H720PubMed
92.
go back to reference Stiles GL, Caron MG, Lefkowitz RJ (1984) Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64:661–743PubMed Stiles GL, Caron MG, Lefkowitz RJ (1984) Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64:661–743PubMed
93.
go back to reference Murad F, Chi YM, Rall TW, Sutherland EW (1962) Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3′,5′-phosphate by preparations from cardiac muscle and liver. J Biol Chem 237:1233–1238PubMed Murad F, Chi YM, Rall TW, Sutherland EW (1962) Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3′,5′-phosphate by preparations from cardiac muscle and liver. J Biol Chem 237:1233–1238PubMed
94.
go back to reference Vincent NH, Ellis S (1963) Inhibitory effect of acetylcholine on glycogenolysis in the isolated guinea-pig heart. J Pharmacol Exp Ther 139:60–68PubMed Vincent NH, Ellis S (1963) Inhibitory effect of acetylcholine on glycogenolysis in the isolated guinea-pig heart. J Pharmacol Exp Ther 139:60–68PubMed
95.
96.
go back to reference Warner MR, Senanayake PD, Ferrario CM, Levy MN (1991) Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. Circ Res 69(2):455–465PubMedCrossRef Warner MR, Senanayake PD, Ferrario CM, Levy MN (1991) Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. Circ Res 69(2):455–465PubMedCrossRef
97.
go back to reference Warner MR, Levy MN (1990) Sinus and atrioventricular nodal distribution of sympathetic fibers that contain neuropeptide Y. Circ Res 67(3):713–721PubMedCrossRef Warner MR, Levy MN (1990) Sinus and atrioventricular nodal distribution of sympathetic fibers that contain neuropeptide Y. Circ Res 67(3):713–721PubMedCrossRef
98.
go back to reference Warner MR, Levy MN (1989) Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res 65(6):1536–1546PubMedCrossRef Warner MR, Levy MN (1989) Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res 65(6):1536–1546PubMedCrossRef
99.
go back to reference Warner MR, Levy MN (1989) Neuropeptide Y as a putative modulator of the vagal effects on heart rate. Circ Res 64(5):882–889PubMedCrossRef Warner MR, Levy MN (1989) Neuropeptide Y as a putative modulator of the vagal effects on heart rate. Circ Res 64(5):882–889PubMedCrossRef
100.
go back to reference Herring N, Lokale MN, Danson EJ, Heaton DA, Paterson DJ (2008) Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. J Mol Cell Cardiol 44:477–485PubMedCrossRef Herring N, Lokale MN, Danson EJ, Heaton DA, Paterson DJ (2008) Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. J Mol Cell Cardiol 44:477–485PubMedCrossRef
101.
go back to reference Anderson FL, Kralios AC, Hershberger R, Bristow MR (1988) Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J of Cardiovasc Pharmacol 12:365–371CrossRef Anderson FL, Kralios AC, Hershberger R, Bristow MR (1988) Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J of Cardiovasc Pharmacol 12:365–371CrossRef
102.
go back to reference Wetzel GT, Brown JH (1985) Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. Am J Physiol 248:H33–H39PubMed Wetzel GT, Brown JH (1985) Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. Am J Physiol 248:H33–H39PubMed
103.
go back to reference Wetzel GT, Goldstein D, Brown JH (1985) Acetylcholine release from rat atria can be regulated through an alpha 1-adrenergic receptor. Circ Res 56:763–766PubMedCrossRef Wetzel GT, Goldstein D, Brown JH (1985) Acetylcholine release from rat atria can be regulated through an alpha 1-adrenergic receptor. Circ Res 56:763–766PubMedCrossRef
104.
go back to reference Brack KE, Coote JH, Ng GA (2011) Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. Cardiovasc Res 91:437–446PubMedCrossRef Brack KE, Coote JH, Ng GA (2011) Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. Cardiovasc Res 91:437–446PubMedCrossRef
105.
go back to reference Jaiswal N, Lambrecht G, Mutschler E, Malik KU (1989) Effect of M2muscarinic receptor antagonist 4-DAMP, on prostaglandin synthesis and mechanical function in the isolated rabbit heart. Gen Pharmacol 20:497–502PubMedCrossRef Jaiswal N, Lambrecht G, Mutschler E, Malik KU (1989) Effect of M2muscarinic receptor antagonist 4-DAMP, on prostaglandin synthesis and mechanical function in the isolated rabbit heart. Gen Pharmacol 20:497–502PubMedCrossRef
106.
go back to reference Wang H, Wang Z (2007) Function of cardiac M3 receptors. Auton Autocoid Pharamcol 27:1–11CrossRef Wang H, Wang Z (2007) Function of cardiac M3 receptors. Auton Autocoid Pharamcol 27:1–11CrossRef
107.
go back to reference Liu Y, Sung HL, Wang LY, Goa Y, Wang YP, Du ZM, Lu YJ, Yang BF (2008) Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism. Can J Physiol Pharmacol 86:860–865PubMedCrossRef Liu Y, Sung HL, Wang LY, Goa Y, Wang YP, Du ZM, Lu YJ, Yang BF (2008) Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism. Can J Physiol Pharmacol 86:860–865PubMedCrossRef
108.
go back to reference Liu Y, Sun L, Pan Z, Bai Y, Wang N, Zhao J, Xu C, Li Z, Li B, Du Z, Lu Y, Gao X, Yang B (2011) Overexpression of m(3) muscarinic receptors is a novel strategy for preventing sudden cardiac death in transgenic mice. Mol Med 17(11–12):1179–1187PubMed Liu Y, Sun L, Pan Z, Bai Y, Wang N, Zhao J, Xu C, Li Z, Li B, Du Z, Lu Y, Gao X, Yang B (2011) Overexpression of m(3) muscarinic receptors is a novel strategy for preventing sudden cardiac death in transgenic mice. Mol Med 17(11–12):1179–1187PubMed
109.
go back to reference Liu Y, Xu C, Jiao J, Wang H, Dong D, Yang B (2005) M3-R/IKM3—a new target of antiarrhythmic agents. Acta Pharmace Sinica 40:8–12 Liu Y, Xu C, Jiao J, Wang H, Dong D, Yang B (2005) M3-R/IKM3—a new target of antiarrhythmic agents. Acta Pharmace Sinica 40:8–12
110.
go back to reference Wang S, Han H, Jiang Y, Wang C, Song H, Pan Z, Fan K, Du J, Fan Y, Du Z, Liu Y (2012) Activation of cardiac M3 Muscarinic acetylcholine has cardioprotective effects against ischemia-induced arrhythmias. Clin Exp Pharmacol Physiol 39(4):343–349PubMedCrossRef Wang S, Han H, Jiang Y, Wang C, Song H, Pan Z, Fan K, Du J, Fan Y, Du Z, Liu Y (2012) Activation of cardiac M3 Muscarinic acetylcholine has cardioprotective effects against ischemia-induced arrhythmias. Clin Exp Pharmacol Physiol 39(4):343–349PubMedCrossRef
111.
go back to reference Ando M, Katare RG, Katinuma Y, Zhang D, Yamasaki F, Muramoto, Sato T (2005) Efferent vagal nerve stimulation protects the heart against ischemia-induced arrhythmias by preserving connexin43 protein 112:164–170 Ando M, Katare RG, Katinuma Y, Zhang D, Yamasaki F, Muramoto, Sato T (2005) Efferent vagal nerve stimulation protects the heart against ischemia-induced arrhythmias by preserving connexin43 protein 112:164–170
112.
go back to reference Martins JB, Zipes DP (1980) Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle. Circ Res 46:100–110PubMedCrossRef Martins JB, Zipes DP (1980) Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle. Circ Res 46:100–110PubMedCrossRef
113.
go back to reference Mantravadi R, Gabris B, Liu T, Choi BR, de Groat WC, Ng GA, Salama G (2007) Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts. Circ Res 100:e72–e80PubMedCrossRef Mantravadi R, Gabris B, Liu T, Choi BR, de Groat WC, Ng GA, Salama G (2007) Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts. Circ Res 100:e72–e80PubMedCrossRef
114.
go back to reference Vaillant F, Timour Q, Descotes J, Manati W, Belhani D, Bui-Xuan B, Tabib A, Bricca G, Chevalier P (2008) Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol 52:548–554PubMedCrossRef Vaillant F, Timour Q, Descotes J, Manati W, Belhani D, Bui-Xuan B, Tabib A, Bricca G, Chevalier P (2008) Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol 52:548–554PubMedCrossRef
115.
go back to reference Koncz I, Szél T, Bitay M, Cerbai E, Jaeger K, Fülöp F, Jost N, Virág L, Orvos P, Tálosi L, Kristóf A, Baczkó I, Papp JG, Varró A (2011) As Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions. Eur J Pharmacol 668:419–426PubMedCrossRef Koncz I, Szél T, Bitay M, Cerbai E, Jaeger K, Fülöp F, Jost N, Virág L, Orvos P, Tálosi L, Kristóf A, Baczkó I, Papp JG, Varró A (2011) As Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions. Eur J Pharmacol 668:419–426PubMedCrossRef
116.
go back to reference Tavazzi L (2003) Heart rate as a therapeutic target in heart failure? Eur Heart J 5(Supp G):G15–G18 Tavazzi L (2003) Heart rate as a therapeutic target in heart failure? Eur Heart J 5(Supp G):G15–G18
117.
go back to reference Weidmann S (1952) The electrical constants of Purkinji fibres. J Physiol 118(3):348–360PubMed Weidmann S (1952) The electrical constants of Purkinji fibres. J Physiol 118(3):348–360PubMed
118.
go back to reference Singh BN, Sarma JS, Zhang ZH, Takanaka C (1992) Controlling cardiac arrhythmia by lengthening repolarisation: rationale from experimental and clinical considerations. Ann NY Acad Sci 644:187–209PubMedCrossRef Singh BN, Sarma JS, Zhang ZH, Takanaka C (1992) Controlling cardiac arrhythmia by lengthening repolarisation: rationale from experimental and clinical considerations. Ann NY Acad Sci 644:187–209PubMedCrossRef
119.
go back to reference Singh BN (1993) Arrythymia control by prolonging repolarisation: the concept and its potential therapeutic impact. Eur Heart J 14:14–23PubMedCrossRef Singh BN (1993) Arrythymia control by prolonging repolarisation: the concept and its potential therapeutic impact. Eur Heart J 14:14–23PubMedCrossRef
120.
go back to reference Kuo C, Munakata K, Reddy C, Surawicz B (1983) Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67:1356–1367PubMedCrossRef Kuo C, Munakata K, Reddy C, Surawicz B (1983) Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67:1356–1367PubMedCrossRef
121.
go back to reference Winter J, Tanko AS, Brack KE, Coote JH, Ng GA (2011) Differential cardiac responses to unilateral sympathetic nerve stimulation in the isolated innervated rabbit heart. Auton Neurosci Basic Clinical 166:4–14CrossRef Winter J, Tanko AS, Brack KE, Coote JH, Ng GA (2011) Differential cardiac responses to unilateral sympathetic nerve stimulation in the isolated innervated rabbit heart. Auton Neurosci Basic Clinical 166:4–14CrossRef
122.
123.
go back to reference Kawano H, Okada R, Yano K (2003) Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18:32–39PubMedCrossRef Kawano H, Okada R, Yano K (2003) Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18:32–39PubMedCrossRef
124.
go back to reference Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMed Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMed
125.
go back to reference Massion PB, Feron O, Dessy C, Balligand J-L (2003) Nitric oxide and cardiac function. Circ Res 93:388–398PubMedCrossRef Massion PB, Feron O, Dessy C, Balligand J-L (2003) Nitric oxide and cardiac function. Circ Res 93:388–398PubMedCrossRef
126.
go back to reference Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156–167PubMedCrossRef Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156–167PubMedCrossRef
127.
go back to reference Guix FX, Uribesalgo I, Coma M, Muňoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Progr Neurobiol 76:126–152CrossRef Guix FX, Uribesalgo I, Coma M, Muňoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Progr Neurobiol 76:126–152CrossRef
128.
129.
go back to reference Conlon K, Kidd C (1999) Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. J Auton Nerv Syst 75:136–146PubMedCrossRef Conlon K, Kidd C (1999) Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. J Auton Nerv Syst 75:136–146PubMedCrossRef
130.
go back to reference Herring N, Golding S, Paterson DJ (2000) Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria. J Mol Cell Cardiol 32:1795–1804PubMedCrossRef Herring N, Golding S, Paterson DJ (2000) Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria. J Mol Cell Cardiol 32:1795–1804PubMedCrossRef
131.
go back to reference Brack KE, Patel VH, Coote JH, Ng GA (2007) Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart. J Physiol 583:695–704PubMedCrossRef Brack KE, Patel VH, Coote JH, Ng GA (2007) Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart. J Physiol 583:695–704PubMedCrossRef
132.
go back to reference Kumar K, Nguyen K, Waxman S, Nearing BD, Wellenius GA, Zhao SX, Verrier RL (2003) Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. J Am Coll Cardiol 41:1831–1837PubMedCrossRef Kumar K, Nguyen K, Waxman S, Nearing BD, Wellenius GA, Zhao SX, Verrier RL (2003) Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. J Am Coll Cardiol 41:1831–1837PubMedCrossRef
133.
go back to reference Patel VH, Brack KE, Coote JH, Ng GA (2004) The effect of nitric oxide on electrical restitution and ventricular fibrillation in the isolated rabbit heart: mechanism underlying the antifibrillatory effects of vagus nerve activity. Eur Heart J 25:68 (ABSTRACT) Patel VH, Brack KE, Coote JH, Ng GA (2004) The effect of nitric oxide on electrical restitution and ventricular fibrillation in the isolated rabbit heart: mechanism underlying the antifibrillatory effects of vagus nerve activity. Eur Heart J 25:68 (ABSTRACT)
134.
go back to reference Brack KE, Patel VH, Mantravardi R, Coote JH, Ng GA (2009) Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J Physiol 587:3045–3054PubMedCrossRef Brack KE, Patel VH, Mantravardi R, Coote JH, Ng GA (2009) Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J Physiol 587:3045–3054PubMedCrossRef
135.
go back to reference Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM, Berger RD (1998) Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Investig 102:1279–1285PubMedCrossRef Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM, Berger RD (1998) Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Investig 102:1279–1285PubMedCrossRef
137.
go back to reference Singh S, Gray T, Wurster RD (2009) Nitric oxide and carbon monoxide synthesizing enzymes and soluble guanylyl cyclase within neurons of adult human cardiac ganglia. Auton Neurosci Basic Clinical 145:93–98CrossRef Singh S, Gray T, Wurster RD (2009) Nitric oxide and carbon monoxide synthesizing enzymes and soluble guanylyl cyclase within neurons of adult human cardiac ganglia. Auton Neurosci Basic Clinical 145:93–98CrossRef
138.
go back to reference Pupo AS, Minneman KP (2002) Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. BMC Pharmacol 2:17PubMedCrossRef Pupo AS, Minneman KP (2002) Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. BMC Pharmacol 2:17PubMedCrossRef
139.
go back to reference Hoover DB, Isaacs ER, Jaques F, Hoard JL, Page P, Armour JA (2009) Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience 164(3):1170–1179 Hoover DB, Isaacs ER, Jaques F, Hoard JL, Page P, Armour JA (2009) Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience 164(3):1170–1179
140.
141.
go back to reference Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003) Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation. Nature 421:384–388PubMedCrossRef Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003) Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation. Nature 421:384–388PubMedCrossRef
142.
go back to reference Li W, Olshansky B (2011) Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev 16:137–145PubMedCrossRef Li W, Olshansky B (2011) Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev 16:137–145PubMedCrossRef
143.
go back to reference Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13:178–184PubMed Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13:178–184PubMed
144.
go back to reference Corrado D, Basso C, Thiene G (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50:399–408PubMedCrossRef Corrado D, Basso C, Thiene G (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50:399–408PubMedCrossRef
145.
go back to reference Chugh SS, Kelly KL, Titus JL (2000) Sudden cardiac death with apparently normal heart. Circulation 102:649–654PubMedCrossRef Chugh SS, Kelly KL, Titus JL (2000) Sudden cardiac death with apparently normal heart. Circulation 102:649–654PubMedCrossRef
146.
go back to reference Klein RM, Vester EG, Brehm MU, Dees H, Picard F, Niederacher D, Beckmann MW, Strauer BE (2000) Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol 89(Suppl 3):24–35PubMed Klein RM, Vester EG, Brehm MU, Dees H, Picard F, Niederacher D, Beckmann MW, Strauer BE (2000) Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol 89(Suppl 3):24–35PubMed
147.
go back to reference London B, Baker LC, Lee JS, Shusterman V, Choi B-R, Kubota T, McTiernan CF, Feldman AM, Salama G (2003) Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284:H431–H441PubMed London B, Baker LC, Lee JS, Shusterman V, Choi B-R, Kubota T, McTiernan CF, Feldman AM, Salama G (2003) Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284:H431–H441PubMed
148.
go back to reference Janczewski AM, Kadokami T, Lemster B, Frye CS, McTiernan CF, Feldman AM (2003) Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-α. Am J Physiol Heart Circ Physiol 284:H960–H969PubMed Janczewski AM, Kadokami T, Lemster B, Frye CS, McTiernan CF, Feldman AM (2003) Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-α. Am J Physiol Heart Circ Physiol 284:H960–H969PubMed
149.
go back to reference Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G (2006) Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 290:H2098–H2107PubMedCrossRef Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G (2006) Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 290:H2098–H2107PubMedCrossRef
150.
go back to reference Taggart P, Critchley H, Lambiase PD (2011) Heart-brain interactions in cardiac arrhythmia. Heart 97(9):698–708PubMedCrossRef Taggart P, Critchley H, Lambiase PD (2011) Heart-brain interactions in cardiac arrhythmia. Heart 97(9):698–708PubMedCrossRef
Metadata
Title
Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure
Authors
Kieran E. Brack
James Winter
G. André Ng
Publication date
01-07-2013
Publisher
Springer US
Published in
Heart Failure Reviews / Issue 4/2013
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-012-9314-2

Other articles of this Issue 4/2013

Heart Failure Reviews 4/2013 Go to the issue